Deni M. Zodda PhD

Deni M. Zodda PhD discloses dealings in 2 companies, chiefly Windtree Therapeutics Inc and Novadel Pharma Inc. Between 21 July 2005 and 6 February 2008, the trades on record add up to 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 7 February 2008: a share grant, in Novadel Pharma Inc. Filings reach the SEC (Form 4) feed a median of 39 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.